Trials / Unknown
UnknownNCT05279638
ATG5 as a Serum Marker of Autophagy in Psoriatic Patient
Evaluation of ATG5 as Aserum Marker of Autophgy in Psoriasis Vulgaris Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
it will be of interest to know the ATG 5 as a serum marker of autophagy in serum of psoriasis vulgairs patients and explore its relationship with psoriasis severity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | serum ATG5 | This kit is used to assay the Autophagy protein 5(ATG5) in the sample of human's serum, blood plasma, and other related tissue Liquid |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2023-02-01
- Completion
- 2024-01-01
- First posted
- 2022-03-15
- Last updated
- 2022-03-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05279638. Inclusion in this directory is not an endorsement.